RAC 0.93% $1.62 race oncology ltd

RAC - Charts & Price Action, page-35

  1. 552 Posts.
    lightbulb Created with Sketch. 93
    Couldn't disagree more. The market responded to Sheba trials, then the recent placement. COH wasn't part of the five path plan. If the announcement simply credits COH as further underpinning previous positive results, then that's +

    Thoughts and desires for a partnership are simply that. Delivering on the five path strategy is what matters. Steadily, and transparently. We have seen that 100%, despite protestations from some who sold out.
    Last edited by cpinvest: 14/07/20
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.